Time Constant Setting for Adaptive Servo-Ventilation (ASV)
Critical Safety Consideration First
ASV is absolutely contraindicated in patients with heart failure and left ventricular ejection fraction (LVEF) ≤45% with moderate or severe central sleep apnea (CSA), as this population demonstrated increased all-cause and cardiovascular mortality in the SERVE-HF trial. 1, 2
Understanding Time Constant in ASV Context
ASV devices do not use a traditional "time constant" setting like conventional ventilators. Instead, ASV operates through a three-minute moving average algorithm that continuously monitors and adjusts to maintain a target minute ventilation, typically set at 90% of the patient's recent minute ventilation. 2 This dynamic adjustment occurs breath-by-breath without requiring manual time constant configuration. 2
Appropriate ASV Parameter Settings
Baseline Pressure Configuration
- ASV provides a baseline CPAP (typically 8 cmH₂O) combined with dynamic inspiratory pressure support (IPS) that ranges from 3-82 cmH₂O above baseline. 1
- The cumulative positive airway pressure during sleep typically ranges from 8 to 16 cmH₂O with ASV therapy. 1, 2
Ventilatory Support Characteristics
- The device automatically adjusts inspiratory pressure support breath-by-breath based on the patient's ventilatory pattern, maintaining approximately 80% of prevailing minute ventilation. 1
- This adaptive mechanism provides periodic ventilatory support during central apneas while functioning as a hybrid system combining CPAP and ventilatory assistance. 1, 2
Clinical Application Algorithm
Step 1: Determine Patient Eligibility
- Obtain ejection fraction measurement before considering ASV—this is the critical safety determinant. 2
- Confirm LVEF >45% if patient has heart failure with CSA. 2, 3
- Document that patient has failed standard CPAP and BPAP with backup rate before progressing to ASV. 2
Step 2: Appropriate Patient Populations
ASV may be considered for:
- Treatment-emergent CSA (complex sleep apnea) after appropriate CPAP trial—this represents 80% of respirology setting indications. 3
- CSA in heart failure patients with LVEF >45% only, with close monitoring. 2, 3
- Hypocapnic central sleep apnea with chronic hyperventilation from neurological disorders or idiopathic causes. 4
Step 3: Expected Outcomes and Monitoring
- Compliant patients (>3 hours per night) demonstrate reduction in apnea-hypopnea index from approximately 47/hour to 7/hour. 4
- Mean nocturnal oxygen saturation improves from 92% to 94%. 4
- Epworth Sleepiness Scale scores decrease from 10 to 6.5 in compliant patients. 4
- Heart failure patients show improvement in NYHA functional class. 4
Common Pitfalls and How to Avoid Them
Contraindication Violation
- 16% of cardiac patients and 9% of respirology patients in one analysis were receiving ASV despite meeting contraindication criteria (CSA with LVEF ≤45%). 3
- Always verify current ejection fraction before initiating or continuing ASV therapy. 2, 3
Inadequate Compliance
- Non-compliant patients (<3 hours per night) do not achieve symptomatic improvement despite adequate device settings. 4
- Mean compliance in successful cases ranges from 5.2 to 5.9 hours per night. 4
Bypassing Treatment Hierarchy
- The American Academy of Sleep Medicine recommends stepwise progression: standard CPAP first, then BPAP with backup rate if CPAP fails, and ASV only if BPAP proves inadequate and LVEF >45%. 2
- Skipping this algorithm exposes patients to unnecessary risk and cost. 2
Mechanism Misunderstanding
- The device's three-minute moving average prevents both under-ventilation and over-ventilation automatically. 2
- Manual "time constant" adjustment is not part of ASV operation—the algorithm handles temporal ventilatory adjustments dynamically. 2
- Attempting to apply conventional ventilator time constant concepts to ASV reflects fundamental misunderstanding of the technology. 1, 2